Loading

A New Era in Organ Transplantation: Advancing Xenotransplantation with Genetic Engineering

June 19, 2025
Breakout Session
Business Development and Investment
252AB
The recent landmark success of gene-edited porcine kidney transplants into human recipients marks a turning point in the future of organ transplantation. With genetic engineering enabling immune-compatible organs, xenotransplantation is now a viable solution to address the critical organ shortage crisis. This panel will explore the scientific breakthroughs that made this possible, including CRISPR gene editing, immune system modulation, and advancements in bioengineering. Experts will discuss the clinical implications, regulatory considerations, and the path forward to making genetically engineered organs an option for patients in need. Join us for a deep dive into how this innovation is reshaping transplant medicine and what’s next for the field.
Moderator
Angelika Fretzen, PhD, MBA
Chief Operating Officer and Technology Translation Director
Wyss Institute
Speakers
Mike Curtis, PhD
CEO
eGenesis
David-Alexandre C. Gros, MD
CEO
Eledon
Alex Morgan, PhD
Partner
Khosla Ventures
Leonardo Riella, MD, PhD
Harold and Ellen Danser Endowed Chair in Transplantation and Associate Professor of Medicine
Massachusetts General Hospital, Harvard Medical School
Xiaoxi (Sofie) Wei, PhD
CEO & Co-Founder
X-Therma
Back to Session List

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS